Global Blood Stream Infection Testing Market 2016-2020 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Blood Stream Infection Testing Market 2016-2020" report to their offering.

The global blood stream infection testing market to grow at a CAGR of 7.75% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global blood stream infection testing market for 2016-2020. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top four vendors operating in the market. The report also includes a discussion of the key vendors operating in this market.

The presence of bacteria and fungi in blood leads to blood stream infections. Bacteria and fungi enter into the blood and cause severe complications and infections such as pneumonia, meningitis, sepsis and AIDS. Bloodstream infections are caused when bacteria enter the bloodstream; this may occur through a wound, injection, or through a surgical procedure. Symptoms of bacteremia may include fever, chills, malaise, nausea, diarrhea, shortness of breath, and vomiting.

One of latest trends in the market is focus on early diagnosis. Blood stream infection is associated with high mortality rates. If blood stream infection has not been diagnosed in the early stage, it continues to be severe and becomes life-threatening. Sepsis is one of the major blood stream infections that leads to death in new-born and children.

Key vendors

• BD
• bioMérieux
• Cepheid
• Roche Diagnostics
• Thermo Fisher Scientific

Other prominent vendors

• IRIDICA
• Alere
• Beckman Coulter
• Bruker
• Nanosphere
• Siemens
• Dade Behring
• AdvanDX
• Eurogentec
• AB Sciex
  

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by product

Part 07: Market segmentation by application

Part 08: Market segmentation by technology

Part 09: Market segmentation by end-user

Part 10: Geographical segmentation

Part 11: Market drivers

Part 12: Impact of drivers

Part 13: Market challenges

Part 14: Impact of drivers and challenges

Part 15: Market trends

Part 16: Vendor landscape

Part 17: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/7rl9mp/global_blood